Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bioject Medical Technologies Inc Announces Appointment OF President And CEO-Form 8-K

Wednesday, 20 Feb 2013 09:32pm EST 

Bioject Medical Technologies Inc reported in its Form 8-K that on February 15, 2013, Bioject Medical Technologies Inc. (Company) entered into an employment agreement with Mr. Mark Logomasini. Pursuant to the Agreement, Mr. Logomasini will formally serve as the President and Chief Executive Officer (CEO) of the Company effective February 15, 2013. 

Company Quote

-0.0337 -17.74%
21 Nov 2014